On‐Surface Synthesis of NBN‐Doped Zigzag‐Edged Graphene Nanoribbons
摘要:
AbstractWe report the first bottom‐up synthesis of NBN‐doped zigzag‐edged GNRs (NBN‐ZGNR1 and NBN‐ZGNR2) through surface‐assisted polymerization and cyclodehydrogenation based on two U‐shaped molecular precursors with an NBN unit preinstalled at the zigzag edge. The resultant zigzag‐edge topologies of GNRs are elucidated by high‐resolution scanning tunneling microscopy (STM) in combination with noncontact atomic force microscopy (nc‐AFM). Scanning tunneling spectroscopy (STS) measurements and density functional theory (DFT) calculations reveal that the electronic structures of NBN‐ZGNR1 and NBN‐ZGNR2 are significantly different from those of their corresponding pristine fully‐carbon‐based ZGNRs. Additionally, DFT calculations predict that the electronic structures of NBN‐ZGNRs can be further tailored to be gapless and metallic through one‐electron oxidation of each NBN unit into the corresponding radical cations. This work reported herein provides a feasible strategy for the synthesis of GNRs with stable zigzag edges yet tunable electronic properties.
COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF
申请人:DUK SAN NEOLUX CO., LTD.
公开号:US20200172524A1
公开(公告)日:2020-06-04
Provided are a compound of Formula 1; an organic electric element comprising a first electrode, a second electrode, and an organic material layer formed between the first electrode and the second electrode, comprising a compound of Formula 1 in the organic material layer; and an electronic device comprising the element, which has lowered driving voltage and increased luminous efficiency and life time.
[EN] CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] COMPOSÉS CYCLIQUES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
申请人:POLYMEDIX INC
公开号:WO2013090185A1
公开(公告)日:2013-06-20
The present invention provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.
Synthetic Mimics of Antimicrobial Peptides with Immunomodulatory Responses
作者:Hitesh D. Thaker、Abhigyan Som、Furkan Ayaz、Dahui Lui、Wenxi Pan、Richard W. Scott、Juan Anguita、Gregory N. Tew
DOI:10.1021/ja303304j
日期:2012.7.11
A new series of aryl-based synthetic mimics of antimicrobial peptides (SMAMPs) with antimicrobial activity and selectivity have been developed via systematic tuning of the aromatic groups and charge. The addition of a pendant aromatic group improved the antimicrobial activity against Gram-negative bacteria, while the addition of charge improved the selectivity. SMAMP 4 with six charges and a naphthalene central ring demonstrated a selectivity of 200 against both Staphylococcus aureus and Escherichia coli, compared with a selectivity of 8 for the peptide MSI-78. In addition to the direct antimicrobial activity, SMAMP 4 exhibited specific immunomodulatory activities in macrophages both in the presence and in the absence of lipopolysaccharide, a TLR agonist. SMAMP 4 also induced the production of a neutrophil chemoattractant, murine KC, in mouse primary cells. This is the first nonpeptidic SMAMP demonstrating both good antimicrobial and immunomodulatory activities.